General Information of Drug (ID: DMBVM1Q)

Drug Name
AlphaMedix
Indication
Disease Entry ICD 11 Status REF
Neuroendocrine cancer 2B72.1 Phase 1 [1]
Drug Type
Peptide
Cross-matching ID
PubChem CID
135391001
TTD ID
DDV8H5

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Somatostatin receptor (SSTR) TTOMNR9 NOUNIPROTAC Activator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03466216) Phase 1 Study of AlphaMedix in Adult Subjects With SSTR (+) NET. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Orano Med.